瑞士（IBR ）Institute for Biopharmaceutical Research
IBR Inc. is a Swiss contract research organization with a core competence in inflammation research and a 10 years history of providing preclinical and clinical R&D services for biotechnology and pharmaceutical companies. A multidisciplinary team of scientists, GLP-compliant laboratories and a broad pattern of validated methods cover the drug development process from early lead optimization to clinical studies. Ensuring access to expert knowledge in all phases of the drug development process, IBR Inc. provides cutting edge bioanalytical services, while meeting the regulatory endpoints and time schedule of its customers.